• Modular Learning
  • Resource Database
  • Offerings
    • Partnership Program
    • Seed Fund
    • Modular Learning
    • Resource Database
  • DRIVEN Companies
    DRIVEN Accelerator HubDRIVEN Accelerator Hub
    • Modular Learning
    • Resource Database
    • Offerings
      • Partnership Program
      • Seed Fund
      • Modular Learning
      • Resource Database
    • DRIVEN Companies

      Modular Learning: Operations

      • Home
      • Modular Learning
      • Operations
      Modular LearningOperations
      • Who is the Patient? 4

        • Section1.1
          Introduction
        • Section1.2
          Precision/Personalization, Segmentation, and Incidence/Prevalence
        • Section1.3
          Patient Journey
        • Section1.4
          Expansion/Secondary Indications
      • Standard of Care & Competition 4

        • Section2.1
          Introduction
        • Section2.2
          Unmet Need, Safety, Efficacy, Compliance, Costs
        • Section2.3
          Development Pipeline Analysis/Competitive Intelligence
        • Section2.4
          Competition in Therapeutics (5 forces)
      • Business Model 4

        • Section3.1
          Introduction
        • Section3.2
          Product, Platform or Service
        • Section3.3
          Mission, Vision, Strategy, Tactics, Operations
        • Section3.4
          Who is the Customer?
      • Regulatory 4

        • Section4.1
          Introduction
        • Section4.2
          FDA Introduction
        • Section4.3
          FDA Guidelines
        • Section4.4
          Selecting FDA Consultants
      • Exit/End Goal 4

        • Section5.1
          Introduction
        • Section5.2
          Trade Sales
        • Section5.3
          Sales
        • Section5.4
          Partnerships

        FDA Guidelines

        Introduction

        The FDA seeks to provide scientifically and clinically valid guidance. They also seek to provide consistency, even in the face of rapidly advancing fields. The most common topics for which consensus has been determined are typically written up and publicly available as “FDA Guidance’s” or when harmonized internationally, “International Conference on Harmonization (ICH) Guidance Documents”.

        What

        Guidance documents represent the consensus viewpoints on what experiments to run, and how… and they’re freely available! They are absolutely required reading, spanning nonclinical safety studies, toxicology, ADME, CMC, clinical trial design, statistics, and much, much more.

        When

        Imagine the patient at one end of a chronological spectrum. At the other end is your product concept. When you’re ready to chart the path from patient back to product, these regulatory documents will provide much of the direction.

        Why

        You must understand the consensus agreement on all regulatory topics of relevance to your product.

        Learning Goals

        Understand the types of guidance’s available, and where to find them.

        Resources

        • FDA Guidance Documents

         

        Prev FDA Introduction
        Next Selecting FDA Consultants

        driven logo inverted web

        DRIVEN Accelerator Hub   .   info@drivenacceleratorhub.com   .   NIGMS UT2GM13017

        Founded By

        © 2021 DRIVEN Accelerator Hub. All rights reserved.

        Website by RYCO

        Modal title

        Message modal